FROG vs REGN
Jfrog Ltd (FROG) versus Regeneron Pharmaceuticals Inc (REGN) — a side-by-side from cached financials, not a winner call.
Jfrog Ltd (FROG) is a software - application company listed on US.
Regeneron Pharmaceuticals Inc (REGN) is a biotechnology company listed on US.
Latest reported FROG revenue for 2024-12-31 was $428.5M. Net income was -$69.2M. Revenue was up 22.5% from 2023-12-31 to 2024-12-31. FROG currently screens at market cap $10.44B.
Latest reported REGN revenue for 2025-12-31 was $14.34B. Net income was $4.50B. Revenue was up 1.0% from 2024-12-31 to 2025-12-31. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
FROG currently screens at market cap $10.44B. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
Not investment advice. Open the FROG and REGN stock pages for the full models.
Not investment advice.